Poly (ADP-ribose) polymerase (PARP) inhibitors are a class of pharmacological inhibitors that target the enzyme PARP. These enzymes play a crucial role in the repair of single-strand DNA breaks through the base excision repair pathway. By inhibiting PARP, these drugs prevent the repair of DNA damage in cancer cells, leading to cell death, particularly in cells deficient in other DNA repair mechanisms.
